ARTICLE | Clinical News
Omiganan: Phase III delayed
September 22, 2008 7:00 AM UTC
Migenix said that partner Cutanea would delay the start of Phase III testing of topical Omiganan to 2H09 from this half. Cutanea has exclusive rights to Omiganan for dermatological applications from M...